Table 1

Novel clinical trials (CTs) in phase II/III, phase III, phase II/IV or phase IV (n = 71) (note that phase II/IV and phase IV trials all fell in the drug treatments, stents or other categories (n = 17))

Clinical trial subject

No. of CTs

Country


Bone conditions

3

Iran, USA

Cardiovascular disease

29

Brazil, Canada, China, Finland, Germany, India, Iran, Italy, Mexico, The Netherlands, Russia, South Korea, UK, USA

Cartilage damage

2

Egypt, South Korea

Crohn's Disease

4

UK, USA

Diabetes

2

India, China

Multiple sclerosis

1

USA

Ocular surface disease

2

Malaysia, Thailand

Scleroderma

3

USA

Spinal cord injury

1

India

Drug treatments for stem cell mobilization

11

China, Germany, Italy, South Korea, Turkey, USA

Stents for capturing endothelial progenitor cells

3

China, The Netherlands, Poland

Other (mainly graft-versus-host disease)

3

India, Germany, UK


Bubela et al. BMC Medicine 2012 10:133   doi:10.1186/1741-7015-10-133

Open Data